The antigenic repertoire in chronic ITP may be constrained, as evidenced by the inhibition of the binding of autoantibodies from several ITP patients by either another ITP autoantibody or a monoclonal anti-GPIIb/IIIa antibody. This evidence concerns the gene ITGA2B and autoimmune thrombocytopenic purpura.